NovaBay Pharmaceuticals Inc

Type: Company
Name: NovaBay Pharmaceuticals Inc
Nationality: United States
Web Address: http://www.novabaypharma.com/
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

BioNews [9.26.14]

Top News HeadlineCompanyType Pharmacyclics and Servier Agree to Conclude Pan-HDAC Inhibitor Collaboration Pharmacyclics & ServierEnded Collaboration This Switch Could Make Gilead Sciences, Inc. Stock Billions Gilead Sciences, Inc.Block ... [Published eClinical Trends - Sep 26 2014]
First reported Sep 25 2014 - Updated Sep 26 2014 - 7 reports

NovaBay awarded first large NeutroPhase order in China

Biopharmaceutical company NovaBay Pharmaceuticals (NYSE MKT:NBY) reported on Thursday the receipt of the first order of of 50,000 units for its NeutroPhase Skin and Wound Cleanser from its Chinese partner, China Pioneer Pharma Holdings (HK Stock Code:1345). ... [Published Individual.com - Sep 26 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Short Interest in NovaBay Pharmaceuticals Increases By 187.4% (NBY)

NovaBay Pharmaceuticals (NYSE:NBY) was the target of a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 416,941 shares, a growth of 187.4% from the August 29th total of 145,082 ... [Published American Banking News - Forex - Sep 25 2014]
First reported Sep 24 2014 - Updated Sep 24 2014 - 1 reports

NovaBay creates advisory board

NovaBay Pharmaceuticals Inc. announced that it has created an Optometry Advisory Board to help oversee the development, marketing and medical use of NovaBay’s i-Lid Cleanser.The cleanser is designed to manage blepharitis and dry eye syndrome.The five ... [Published Orthopedics Today - Sep 24 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

NOVABAY PHARMACEUTICALS : Introduces Optometry Advisory Board

NovaBay Pharmaceuticals reported that it has created an Optometry Advisory Board to help oversee the development, marketing and medical use of NovaBay's i-Lid Cleanser and other eye care products.The five members of the new board are nationally known ... [Published 4 Traders - Sep 23 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 6 reports

NovaBay Pharmaceuticals, Inc. Creates Optometry Advisory Board

NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, announced today that it has created an Optometry Advisory Board to help oversee ... [Published BioSpace - Sep 18 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 2 reports

NovaBay Pharmaceuticals Will Feature i-Lid Cleanser for the First Time at Vision Expo West

EMERYVILLE, CA--(BUSINESS WIRE)-- (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products,announced today that the company will be featuring its i-LidTM Cleanser with ... [Published Investor's Business Daily - Sep 16 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 2 reports

Novabay Pharmaceuticals Up 8.0%, Penny Stock Attracts Attention (NBY)

Written on Tue, 09/09/2014 - 1:16pmBy Nick RussoNovabay Pharmaceuticals ( AMEX:NBY ) is one of today's best performing penny stocks, up 8.0% to $0.96 on 1.1x average daily volume. Novabay Pharmaceuticals has traded 483,000 shares thus far today, vs. ... [Published Comtex SmarTrend - Sep 09 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 4 reports

NovaBay Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Healthcare Conference

NovaBay ® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that Ron Najafi, Ph.D., Chairman and CEO,Click to Continue » ... [Published Fort Mills Times - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 2 reports

Stock to Watch: Novabay Pharmaceuticals ...

Novabay Pharmaceuticals (AMEX:NBY) is one of today's best performing penny stocks, up 7.8% to $0.82 on 1.2x average daily volume. Novabay Pharmaceuticals has traded 510,000 shares thus far today, vs. average volume of 442,000 shares per day. The stock ... [Published Financial News Network online - Sep 03 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Novabay Pharmaceuticals Up 5.5%, Penny Stock Attracts Attention (NBY)

Novabay Pharmaceuticals (AMEX:NBY) is one of today's best performing penny stocks, up 5.5% to $0.80 on 1.1x average daily volume. Thus far today, Novabay Pharmaceuticals has traded 465,000 shares, vs. average volume of 442,000 shares per day. The stock ... [Published Individual.com - Sep 03 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 9 reports

NovaBay anti-infective approved in China

News EditorThe China Food and Drug Administration approves NovaBay Pharmaceuticals' (NYSEMKT:NBY) NeutroPhase non-antibiotic skin and wound cleanser. The product will be distributed in China by China Pioneer Pharma Holdings Limited. Shipments to China ... [Published Seeking Alpha - Sep 03 2014]

Quotes

"Garcia's story is a profile in courage," said Jacqueline Roemmele . "He is rebuilding his life after a terrible ordeal. But as NNFF's two other Hispanic heroes have demonstrated, it may be possible in the future to improve the outcomes from this terrible disease, making the consequences less devastating."
"The U S has 32,000 optometrists, who provide eye care services to millions of Americans," said Dr. Ron Najafi , Chairman and CEO of NovaBay. "Our new board will play a vital role getting information to those optometrists about the benefits that i-Lid Cleanser offers to those patients."
...By tracking the size and price of each montha'a "s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin."
"At the same time, China has the highest number of reported cases of necrotizing fasciitis, or 'flesh-eating disease of any nation in the world. NeutroPhase will help with both problems."

More Content

All (91) | News (37) | Reports (0) | Blogs (54) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
BioNews [9.26.14] [Published eClinical Trends - Sep 26 2014]
NovaBay awarded first large NeutroPhase order i... [Published Individual.com - Sep 26 2014]
NovaBay Receives First Large NeutroPhase Order ... [Published Fort Mills Times - Sep 25 2014]
NovaBay Reports Receiving of First Large Neutro... [Published Atlanta Journal And Constitution - Sep 25 2014]
NovaBay Reports Receiving of First Large Neutro... [Published Benzinga.com - Sep 25 2014]
NovaBay Receives First Large NeutroPhase Order ... [Published Business Wire Photo/Multimedia News - Sep 25 2014]
NovaBay Receives First Large NeutroPhase Order ... [Published Business Wire Health News - Sep 25 2014]
NovaBay Receives First Large NeutroPhase Order ... [Published Business Wire News with Multimedia - Sep 25 2014]
Short Interest in NovaBay Pharmaceuticals Incre... [Published American Banking News - Forex - Sep 25 2014]
Hispanic Heroes Honored in Fight Against "Flesh... [Published HispanicBusiness.com - Sep 24 2014]
NovaBay creates advisory board [Published Orthopedics Today - Sep 24 2014]
NOVABAY PHARMACEUTICALS : Introduces Optometry ... [Published 4 Traders - Sep 23 2014]
NovaBay Pharmaceuticals, Inc. Creates Optometry... [Published BioSpace - Sep 18 2014]
NovaBay Pharmaceuticals Creates Optometry Advis... [Published Investor's Business Daily - Sep 18 2014]
NovaBay Pharmaceuticals Creates Optometry Advis... [Published Fort Mills Times - Sep 18 2014]
NovaBay Pharmaceuticals Creates Optometry Advis... [Published Business Wire Photo/Multimedia News - Sep 18 2014]
NovaBay Pharmaceuticals Creates Optometry Advis... [Published Business Wire Health News - Sep 18 2014]
NovaBay Pharmaceuticals Creates Optometry Advis... [Published Business Wire News with Multimedia - Sep 18 2014]
DK, LSTR, HTM, NBY, STV Are Seasonally Ripe To ... [Published Individual.com - Sep 17 2014]
BioNews [9.16.14] [Published eClinical Trends - Sep 16 2014]
NovaBay Pharmaceuticals Will Feature i-Lid Clea... [Published Investor's Business Daily - Sep 16 2014]
NovaBay Pharmaceuticals Will Feature i-Lid Clea... [Published Business Wire Health News - Sep 16 2014]
NovaBay Pharmaceuticals : Hispanic Heroes Honor... [Published 4 Traders - Sep 15 2014]
The Eyes Have It According to Recent VC Funding... [Published I Am Biotech - Sep 15 2014]
Novabay Pharmaceuticals Up 8.0%, Penny Stock At... [Published Comtex SmarTrend - Sep 09 2014]
Novabay Pharmaceuticals Up 8.0%, Penny Stock At... [Published Individual.com - Sep 09 2014]
Week In Review: DXY Receives $70 Million Invest... [Published Seeking Alpha - Sep 08 2014]
NovaBay Pharmaceuticals Reports China's Food an... [Published Individual.com - Sep 08 2014]
NovaBay's Phase II adenoviral conjunctivitis st... [Published Individual.com - Sep 05 2014]
NovaBay Pharmaceuticals to Present at Rodman & ... [Published Fort Mills Times - Sep 05 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioNews [9.26.14] [Published eClinical Trends - Sep 26 2014]
Top News HeadlineCompanyType Pharmacyclics and Servier Agree to Conclude Pan-HDAC Inhibitor Collaboration Pharmacyclics & ServierEnded Collaboration This Switch Could Make Gilead Sciences, Inc. Stock Billions Gilead Sciences, Inc.Block ...
NovaBay Receives First Large NeutroPhase Order ... [Published Business Wire Photo/Multimedia News - Sep 25 2014]
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that its partner China Pioneer ...
NovaBay Receives First Large NeutroPhase Order ... [Published Business Wire Health News - Sep 25 2014]
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that its partner China Pioneer ...
NovaBay Receives First Large NeutroPhase Order ... [Published Business Wire News with Multimedia - Sep 25 2014]
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that its partner China Pioneer ...
NovaBay Pharmaceuticals Creates Optometry Advis... [Published Business Wire Photo/Multimedia News - Sep 18 2014]
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals Creates Optometry Advisory Board ...
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.